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Abstract Sildenafil citrate (Viagra) is a potent and spe-
cific inhibitor of cyclic guanosine monophosphate (cGMP)-
specific phosphodiesterase type 5 (PDE5), which exhibits
cardioprotective action against ischemia/reperfusion injury
in intact and isolated heart. The mechanism of its cardio-
protective action is not completely understood, but some
results suggested that sildenafil exerts cardioprotection
through the opening of mitochondrial ATP-sensitive K+
channels (mitoKATP). However, the impact of sildenafil
citrate per se on isolated heart mitochondrial function is
unknown. The goal of this study was to investigate the
influence of the compound on mitochondrial function
(bioenergetics, Ca2+-induced mitochondrial permeability
transition, and hydrogen peroxide (H2O2) generation) in an
attempt to correlate its known actions with effects on heart
mitochondria. It was observed that sildenafil citrate con-
centrations of up to 50 lM did not significantly affect
glutamate/malate-supported respiration in states 2, 3, 4,
oligomycin-inhibited state 3, and uncoupled respiration.
The respiratory control ratio (RCR), the ADP to oxygen
ratio (ADP/O), the transmembrane potential (DW), the
phosphorylation rate, and the membrane permeability to
H+, K+ and Ca2+ were not affected either. However, sil-
denafil citrate decreased H2O2 generation by mitochondria
respiring glutamate/malate, and also decreased the forma-
tion of superoxide radical (O2
•-) generated in a
hypoxantine/xantine oxidase system. It was concluded that
sildenafil citrate concentrations of up to 50 lM do not
affect either rat heart mitochondrial bioenergetics or Ca2+-
induced mitochondrial permeability transition, but it
depresses H2O2 generation by acting as a superoxide dis-
mutase (SOD)-mimetic. By preventing reactive oxygen
species (ROS) generation, sildenafil citrate may preserve
heart mitochondrial function.
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Introduction
In less than 20 years, sildenafil (1-[[3-(6,7-dihydro-1-methyl-
7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-eth-
oxyphenyl]sulphonyl]-4-methylpiperazine) (Fig. 1), a potent
and specific inhibitor of cyclic guanosine monophosphate
(cGMP)-specific phosphodiesterase type 5 (PDE5), has
evolved from a potential anti-angina drug into an on-demand
oral treatment for erectile dysfunction (Viagra), and more
recently, into a new orally active treatment for pulmonary
arterial hypertension (Revatio) [1]. The action mechanism of
sildenafil citrate is not completely understood, but it is
believed that, by inhibiting the breakdown of nitric oxide
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(NO)-driven cGMP, sildenafil citrate prolongs the relaxation
and vasodilatation actions of cGMP on vascular/corpus cav-
ernosal smooth muscle cells [1–3]. However, more recent
studies have shown that sildenafil citrate also inhibits super-
oxide formation (O2
•-) by NADPH oxidases, suggesting that
the therapeutic action of the compound may be mediated
partly through antioxidant mechanisms [4–6].
Several studies have shown that sildenafil citrate
exhibits a cardioprotective effect against ischemia/reper-
fusion injury in intact and isolated hearts [3, 7–11]. There
is substantial evidence that the vasodilatating properties of
sildenafil is the major factor underlying the cardioprotec-
tion, as vasodilatation would lead to release of endogenous
mediators from endothelial cells (such as adenosine and
bradykinin) leading to phosphorylation of endothelial NO
synthases (NOS) and release of NO. This ultimately leads
(via an increase in cGMP and activation of protein kinase
G (PKG)) to activation of the mitochondrial ATP-sensitive
K+ channels (mitoKATP).
It is widely acknowledged that ischemia/reperfusion
lead to mitochondrial, as well as cellular damage in cardiac
cells. Furthermore, the phenomenological description of
the mitochondrial changes that occur in ischemia/reperfu-
sion injury, together with pharmacological studies on
agents that protect against such changes, suggest that
mitochondrial dysfunction might be important as a major
causative agent in tissue injury and, also, the main target
for intervention to limit the damage [12–15]. However, the
precise mechanism by which sildenafil citrate exerts car-
dioprotection related with its action on mitochondrial
function has not been analysed. Mitochondria, whose main
function is ATP synthesis by oxidative phosphorylation,
are also the most important cellular source of reactive
oxygen species (ROS), the main targets for ROS regulatory
and toxic actions, and the sources of signaling molecules
that command cell cycle, proliferation, and apoptosis [16,
17]. Mitochondria regulate the life and cell death of cells
by manipulating several factors, including bioenergetics,
mitochondrial permeability transition pore, and mitochon-
drial redox-status [12].
The goal of this study was to investigate the effect of
sildenafil citrate on rat heart mitochondrial function (bio-
energetics, Ca2+-induced mitochondrial permeability
transition pore, and hydrogen peroxide (H2O2) generation),
in an attempt to correlate the known actions of the com-
pound with its effects on heart mitochondria. Considering
the interest in elucidating the mechanism of action under-
lying the cardioprotective action of sildenafil citrate, the
results obtained in this study will be a good starting point to
investigate its potential protective effect on mitochondrial
dysfunction induced by ischemia/reperfusion injury. Sil-
denafil citrate concentrations used in this study are within
the concentration range used by other investigators in
protection against necrosis and apoptosis in cardiomyo-
cytes [18].
Materials and methods
Animals
Male Wistar rats (250–350 g), housed at 22 ± 2C under
artificial light for 12-h light/dark cycle and with access to
water and food ad libitum, were used throughout the
experiments. The experiments reported here were carried
out in accordance with the National Requirements for
Vertebrate Animal Research and in accordance with the
European Convention for the Protection of Animals used
for Experimental and other Scientific Purposes.
Isolation of heart mitochondria
Heart mitochondria were prepared from male Wistar rats
(6 weeks) by differential centrifugation according to con-
ventional methods [19] with slight modifications. Briefly,
the hearts were finely minced in an ice-cold isolation
medium containing 250 mM sucrose, 1 mM EGTA,
10 mM Tris–HCl (pH 7.4), and 0.1% defatted bovine
serum albumin (BSA). The minced tissue was suspended in
20 ml of isolation medium and homogenized with a tightly
fitted homogenizer (Teflon/glass). Then, 0.5 mg protease
type VIII (Sigma, P5390) per g of tissue plus 20 ml of
Fig. 1 Molecular structure of sildenafil
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isolation medium was added to the homogenate. The sus-
pension was incubated for 1 min at 4C and then re-
homogenized. The homogenate was centrifuged at 9,500g
for 10 min. The supernatant was decanted and the pellet
was gently re-suspended, in isolation medium, to its ori-
ginal volume. The suspension was centrifuged at 900g for
10 min, and the resulting supernatant was centrifuged at
9,500g for 10 min. The pellet was resuspended in 40 ml of
washing medium (250 mM sucrose, 10 mM Tris–HCl, pH
7.2), and re-pelleted twice at 9,500g for 10 min. Finally,
the pellet was resuspended in 0.5 ml of washing medium
(at a protein concentration of about 17 mg ml-1) and
stored in ice. Heart mitochondrial preparations isolated by
this procedure correspond to heterogeneous populations of
subsarcolemmal and interfibrillar mitochondria. Protein
content was determined by the biuret method [20], using
BSA as a standard.
Measurement of respiratory activities
Oxygen consumption was polarographically monitored
with a Clark-type electrode, in a closed glass chamber
equipped with magnetic stirring, thermostated at 30C.
Mitochondrial protein (0.5 mg) was incubated in 1 ml of
medium containing 130 mM sucrose, 5 mM Hepes (pH
7.2), 50 mM KCl, 2.5 mM K2HPO4, 2.5 mM MgCl2,
0.1 mM EGTA in the absence and presence of sildenafil
citrate for 3 min. At the end of the incubation time,
mitochondrial protein was energised by adding 10 mM
glutamate/5 mM malate. In order to induce state 3 respi-
ration, adenosine diphosphate (ADP, 200 lM) was added.
Inhibition of state 3 respiration was induced by adding
1 lg/ml oligomycin. Uncoupled respiration was initiated
by the addition of 1 lM p-trifluoromethoxyphenylhydraz-
one (FCCP). O2 consumption was calculated taking the
saturation oxygen concentration to be 240 nmol O2 ml
-1.
The respiratory control ratio (RCR) and ADP to oxygen
ratio (ADP/O) were calculated in accordance with a pre-
viously described method [21].
Measurement of mitochondrial transmembrane
potential
The mitochondrial transmembrane potential (Dw) was
measured in an open glass chamber equipped with mag-
netic stirring, thermostated at 30C, using a lipophilic
cation tetraphenylphosphonium (TPP+)-selective electrode,
as previously described [22]. To 1 ml of medium con-
taining 130 mM sucrose, 5 mM Hepes (pH 7.2), 50 mM
KCl, 2.5 mM K2HPO4, 2.5 mM MgCl2, 0.1 mM EGTA,
supplemented with 3 lM TPP+ and 10 mM glutamate/
5 mM malate, in the absence and presence of sildenafil
citrate, 0.5 mg mitochondrial protein was added. In order
to induce phosphorylation, adenosine diphosphate (ADP,
200 lM) was added. No correction was made for the
‘‘passive’’ binding of TPP+ to the mitochondria membranes
because the purpose of the experiments was to show rela-
tive changes in potential rather than absolute values. As
a consequence, we can anticipate some overestimation
for the Dw values. Sildenafil citrate did not affect TPP+
binding to mitochondria membranes or the electrode
response.
Mitochondrial swelling
Mitochondrial osmotic volume changes were measured by
the apparent absorbancy changes at 540 nm with a suitable
spectrophotometer-recorder set up. Mitochondrial swelling
methods were used to detect H+ and K+ mitochondrial
inner membrane permeabilisation [23]. The reactions were
carried out at 30C, with 0.5 mg mitochondrial protein
suspended in 2.5 ml of the required media, as described
below.
Mitochondrial inner membrane permeabilisation to H+
by sildenafil citrate was detected in K-acetate medium
(135 mM K-acetate, 5 mM Hepes (pH 7.1), 0.1 mM
EGTA, and 0.2 mM EDTA) supplemented with 2 lM
rotenone. All assays were performed in the presence of
1 lg/ml valinomycin to permeabilise to K+. A control
assay was performed in the presence of 1 lM FCCP for
total permeabilisation to H+.
In order to detect K+ mitochondrial inner membrane
permeabilisation by sildenafil citrate, we used K-nitrate
medium (135 mM KNO3, 5 mM Hepes (pH 7.1), 0.1 mM
EGTA, and 0.2 mM EDTA) supplemented with 2 lM
rotenone. Control assay was performed in the presence of
1 lg/ml valinomycin for total permeabilisation to K+.
Ca2+-induced mitochondrial membrane transition pore
(MPT)
In order to detect Ca2+-induced MPT, we used a TPP+
electrode and a medium containing 200 mM sucrose,
10 mM Mops–Tris (pH 7.4), 5 mM KH2PO4, 10 lM
EGTA, supplemented with 2 lM rotenone, in the absence
and presence of sildenafil citrate. Mitochondrial protein
(0.5 mg), incubated in 1 ml of medium at 30C for 3 min,
was energised with 10 mM succinate, and one addition of
Ca2+ (300 nmol Ca2+) was used to induce MPT. Control
assays, in both absence and presence of Ca2+ plus 1 lM
cyclosporin A (CsA), were also performed.
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Hydrogen peroxide generation
Hydrogen peroxide (H2O2) generation was measured flu-
orimetrically using a modification of the method previously
described [24]. Briefly, mitochondrial protein (0.2 mg) was
incubated at 30C in 1.5 ml of medium containing 5 mM
KH2PO4, pH 7.4, 0.1 mM EGTA, 145 mM KCl, 30 mM
Hepes, 0.1 mM homovanillic acid, and 6 U/ml horseradish
peroxidase. The reactions were started by adding 10 mM
glutamate/5 mM malate and stopped 15 min later with
0.5 ml of cold 0.1 M glycine–NaOH (pH 12) containing
25 mM EDTA. The mitochondrial suspensions were cen-
trifuged at 850g for 10 min. The fluorescence of
supernatants was measured at 312 nm as excitation and
420 nm as emission wavelengths. The peroxide generation
was calculated using a standard curve of H2O2.
Measurement of superoxide dismutase activity
Superoxide dismutase (SOD) activity was evaluated using
a spectrophotometrical assay, as described elsewhere [25].
Detection of SOD activity in this procedure is based on its
ability to inhibit the reduction rate of nitroblue tetrazolium
(NBT) by the superoxide radical (O2
•-) generated in a
hypoxantine/xantine oxidase system. The assays were
performed in 3 ml of reaction medium containing 50 mM
KH2PO4 (pH 7.8), 1 mM EDTA, 100 lM NBT and
100 lM hypoxanthine. The reaction was initiated by the
addition of xanthine oxidase (usually 0.025 U/ml) to pro-
duce a NBT reduction rate of 0.025 absorbancy units per
min at 550 nm and 25C. Sildenafil citrate (10, 20, 30, and
50 lM) was added to the incubation mixture and the
reaction allowed continuing for 3 min at 25C, with con-
tinuous magnetic stirring. The measurements were
performed at 550 nm in a Jasco V560 UV/VIS Spectro-
photometer, against a blank prepared in the absence of
xantine oxidase. One unit of SOD activity was defined as
the amount of enzyme required to inhibit the reduction rate
of NBT by 50%. The SOD-like activity of sildenafil citrate
was calculated using a standard curve prepared with SOD
concentrations.
Statistical analysis
All the experiments were performed using three indepen-
dent experiments with different mitochondrial preparations.
The values are expressed as mean ± SE. Means were
compared using one-way ANOVA test for multiple com-
parisons, followed by the Tukey’s test. Statistical
significance was set at P \ 0.05.
Chemicals
All chemicals were obtained from Sigma Chemical Com-
pany (St Louis, MO, USA) except sildenafil citrate which
was kindly supplied by Sandwich Laboratories, Pfizer
Limited, Sandwich, Kent CT13 9NJ, UK.
Results
Effect of sildenafil citrate on rat heart mitochondrial
bioenergetics
The effects of sildenafil citrate on glutamate/malate-sup-
ported respiratory rates (states 2, 3, 4, oligomycin-inhibited
state 3 (state Olig), and FCCP-uncoupled respiration (state
FCCP)) and respiratory indices RCR and ADP/O ratio of rat
heart mitochondria are almost non-existent and insignificant
at concentrations up to 50 lM (Fig. 2), suggesting that the
compound had no significant effect on the respiratory
capacity or phosphorylation efficiency of mitochondria.
These results are confirmed by Fig. 3, where sildenafil citrate
(50 lM) did not affect either the DW induced by glutamate/
malate-dependent respiration or the phosphorylation
efficiency.
The lack of significant interference of sildenafil citrate
with heart mitochondrial bioenergetics proves no effect on
the respiratory electron chain and agrees with no perme-
abilisation of mitochondrial inner membrane. Our results
confirmed its inability to affect mitochondrial inner mem-
brane permeabilisation to H+ and K+, which were evaluated
by the swelling of non-respiring mitochondria suspended in
potassium acetate and potassium nitrate media, respec-
tively (Fig. 4). Protonated acetate can cross the
mitochondrial inner membrane, and then in the mitochon-
drial matrix, dissociate to the acetate anion and H+,
producing a proton gradient. A valinomycin-dependent
swelling only occurs if the proton gradient is dissipated.
Sildenafil citrate concentrations of up to 50 lM did not
affect the rate of valinomycin-dependent mitochondrial
swelling, indicating a lack of action on proton conductance
through the mitochondrial inner membrane (Fig. 4a).
Optimal swelling in potassium nitrate medium (KNO3) is
observed in conditions of K+ permeabilisation, since the
mitochondrial inner membrane is permeable to nitrate
(NO3
-). Maximal rate of swelling is observed by adding
valinomycin to provide K+ entry. Sildenafil citrate con-
centrations of up to 50 lM added, instead of valinomycin,
did not induce swelling, indicating that the K+ conductance
through the inner mitochondrial membrane was not affec-
ted by the highest tested concentration of sildenafil citrate
(Fig. 4b).
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Effect of sildenafil citrate on Ca2+-induced MPT of rat
heart mitochondria
The effects of sildenafil citrate on the mitochondrial per-
meability transition (MPT) were evaluated by measuring
mitochondrial transmembrane potential (Dw) drop, which
is a typical phenomenon that follows the induction of MPT.
In control conditions, the addition of 10 mM succinate
produced Dw of &-220 mV (Fig. 5). Addition of a pulse
of 300 nmol Ca2+/0.5 mg protein led to a rapid depolar-
isation (decrease of Dw) followed by a partial
repolarisation (recover of Dw) with subsequent total
depolarisation of mitochondria. Mitochondria can tolerate a
certain amount of Ca2+, but ultimately their capacity of
Ca2+-loading is overwhelmed and mitochondria completely
depolarise due to a change in the inner membrane perme-
ability. This is prevented in the presence of 1 lM
cyclosporine A (CsA), a specific inhibitor of MPT [26].
Incubation of mitochondria with sildenafil citrate concen-
trations of up to 50 lM, for 3 min before energisation with
succinate, did not affect the capacity of mitochondria to
accumulate Ca2+, suggesting that this compound has no
ability to affect Ca2+-induced MPT.
Effect of sildenafil citrate on rat heart oxidative stress
The production of H2O2 by mitochondria gives an indication
about the propensity of mitochondria to originate and/or
exacerbate oxidative stress. In the absence of inhibitors of
mitochondrial respiratory chain activity, the levels of H2O2
generated by rat heat mitochondria respiring glutamate/
malate, expressed in nmol H2O2 mg
-1 protein 15 min-1,
were low (2.61 ± 1.0). However, in the presence of 1 lM
rotenone (an inhibitor of complex I) or 10 lM antimycin A
(an inhibitor of complex III) the levels of H2O2 significantly
increased to 8.07 ± 1.89 and 34.13 ± 10.71, respectively.
As a control, we used catalase (643 U/ml) that dismutates
H2O2 to H2O plus O2, to inhibit H2O2 production (with
Antimycin A) from 34.13 ± 10.71 to 3.76 ± 0.77.
We analysed the effect of sildenafil citrate on the gen-
eration of H2O2 (Fig. 6) by mitochondria respiring
glutamate/malate in the absence of inhibitors of the mito-
chondrial respiratory chain activity (Basal) and in the
presence of rotenone (Rot) or antimycin A (AA). Sildenafil
citrate significantly decreased the generation of H2O2 by
mitochondria under all the experimental conditions tested.
The generation of H2O2 by mitochondria respiring
Fig. 2 Effect of sildenafil citrate on the respiratory parameters of rat
heart mitochondria using glutamate/malate as a substrate. Freshly
isolated mitochondria were incubated at 0.5 mg/ml under standard
conditions, as described in the ‘‘Materials and methods’’ section.
Reactions were started by adding glutamate/malate. The traces are
typical recordings representative of three experiments obtained from
different mitochondrial preparations. Trace a, mitochondria in the
absence of sildenafil (Sil); Trace b, mitochondria in the presence of
50 lM Sil. Where indicated by arrows, 10 mM glutamate/5 mM
malate (Glu/Mal); 200 lM ADP; 1 lg/ml oligomycin (Olig), and
0.5 lM FCCP, were added. Numbers on the records and table
underneath are values of activities for state 2, state 3, state 4, state
Olig, and state FCCP expressed in nmol O2 mg
-1 protein min-1. The
table underneath shows the mean ± SE of respiratory parameters at
the different indicated concentrations of Sil
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glutamate/malate decreased 43% by 50 lM sildenafil cit-
rate, while for mitochondria inhibited with rotenone or
antimycin A the percentages were 41% and 30%,
respectively.
Depression of H2O2 production by sildenafil citrate
could be a result of its capacity to scavenge O2
•-, the pri-
mary ROS generated by the mitochondrial respiratory
chain activity [16, 17]. In order to test this hypothesis we
compared the capacities of sildenafil citrate and SOD to
inhibit the reduction rate of NBT induced by the O2
•-
generated in a hypoxanthine/xantine oxidase system
(Fig. 7). In the presence of the O2
•- generating system,
sildenafil citrate concentrations of up to 50 lM inhibited
the reduction rate of NBT in a concentration dependent
manner, indicating that the compound possesses the
capacity to scavenge O2
•-. Considering the relationship
between the SOD-like activity of sildenafil citrate versus its
concentration (Fig. 7, inset), 50 lM sildenafil citrate has a
SOD-like activity corresponding to about 0.85 units of
SOD. This is a result that proves antioxidant capacity for
sildenafil citrate, acting as an O2
•- scavenger.
Discussion
In this study, we analysed the effects of sildenafil citrate on
several heart mitochondrial parameters to correlate known
actions of the compound with effects on heart mitochondria.
One of the main findings of your study was that silde-
nafil citrate concentrations of up to 50 lM did not affect
heart mitochondrial bioenergetics, as shown by the lack of
Fig. 3 Effect of sildenafil citrate on malate/glutamate-dependent
transmembrane potential (DW) and phosphorylation time of rat heart
mitochondria. Freshly isolated mitochondria were incubated at
0.5 mg/ml under standard conditions, as described in the ‘‘Materials
and methods’’ section. Reactions were started by adding mitochon-
dria. The traces are typical recordings representative of three
experiments obtained from different mitochondrial preparations.
Trace a, mitochondria in the absence of sildenafil (Sil); Trace b,
mitochondria in the presence of 50 lM Sil. Where indicated by
arrows, 0.5 mg mitochondria (Mit); and 200 lM ADP were added.
The table underneath shows the mean ± SE of membrane potential,
and phosphorylation time at the different indicated situations
Fig. 4 Effect of sildenafil citrate on the permeabilisation to H+ and
K+ by the inner membrane of rat heart mitochondria, evaluated by
passive osmotic swelling of mitochondria suspended in K-acetate (a)
and KNO3 (b) media, respectively. Freshly isolated heart mitochon-
dria were incubated at 0.5 mg/2.5 ml of appropriate medium, as
described in the ‘‘Materials and methods’’ section. Where indicated
by arrows, 1 lM FCCP; 30 and 50 lM sildenafil citrate (Sil); and
1 lg/ml valinomycin (Val) were added. The traces are typical
recordings representative of three experiments obtained from different
mitochondrial preparations
Fig. 5 Effect of sildenafil citrate (Sil) on Ca2+-induced MPT
evaluated by measuring mitochondrial transmembrane potential
(DW) with a TTP+ electrode. Freshly isolated heart mitochondria
(0.5 mg) were incubated as described in the ‘‘Materials and methods’’
section. Mitochondria were energised with 10 mM succinate (Suc),
and 300 nmol Ca2+ were added, where indicated, to induce MPT. One
micromolar cyclosporin A (CsA) was used to confirm MPT induction.
The traces are typical recordings representative of three experiments
obtained from different mitochondrial preparations
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effects on glutamate/malate-supported respiration in states
2, 3, 4, oligomycin inhibited state 3, FCCP-uncoupled
respiration, RCR and ADP/O ratio (Fig. 2). Consequently,
the DW and the phosphorylation rate were not affected
(Fig. 3). In agreement with these results, we also observed
the inability of the compound to affect nonselective mito-
chondrial inner membrane permeabilisation to H+ and K+
(Fig. 4), indicating that sildenafil citrate concentrations of
up to 50 lM do not impair rat heart mitochondrial func-
tion. The observation that 50 lM of the compound did not
affect MPT (Fig. 5) indicates that the compound did not
interfere with heart mitochondrial Ca2+ homeostasis.
Another main finding was that sildenafil citrate (10, 30,
and 50 lM) protects heart mitochondria against oxidative
stress, as revealed by its ability to depress H2O2 generation
(Fig. 6). This can be a result of its SOD-like activity,
decreasing O2
•- production by mitochondria and, in doing
so, avoiding H2O2 generation. Indeed, like SOD, sildenafil
citrate inhibited the reduction rate of NBT induced by O2
•-
in a concentration dependent manner (Fig. 7). However,
the SOD-like activity of sildenafil citrate cannot be
attributed to dismutation of O2
•- to H2O2, as it is by SOD,
since we observed a decrease, instead of an increase, in the
H2O2 generated by mitochondria. The hypothesis that the
compound affects the activity of xantine oxidase enzyme
cannot be clarified, because sildenafil citrate and ureate’s
spectra overlap at 292 nm [27].
Regardless of the precise mechanism by which sildenafil
citrate depressed the H2O2 generated by heart mitochon-
dria, the results presented in this study are well in line with
previous findings showing that the compound exhibits an
antioxidant effect, thus playing an important role in the
protection against oxidative stress. It prevents cadmium-
and lead-induced oxidative stress in the submandibular
gland and saliva of rats [28, 29] and pulmonary embolism-
induced oxidative stress in the plasma of dogs and rats, as
well as in perfused lung preparations isolated from rats
[30]. It also reduces diabetes-induced oxidative stress of
plasma in streptozotocin-treated rats [31]. Furthermore,
sildenafil citrate inhibits O2
•- formation induced by the
thromboxane A2 analogue U46619, nicotine and tumor
necrosis factor-a in cultured corpus cavernosal smooth
muscle cells derived from rabbit penis [6, 32]. It also
inhibits O2
•- formation in isolated corpus cavernosum from
hypercholesterolaemic rabbits [33] and pig pulmonary
artery endothelial cells [34].
Fig. 6 Effect of sildenafil citrate on hydrogen peroxide (H2O2)
production by rat heart mitochondria. Freshly isolated heart mito-
chondria were incubated at 0.2 mg/1.5 ml in standard conditions as
described in the ‘‘Materials and methods’’ section. Reactions were
started by adding 10 mM glutamate/5 mM malate and stopped 15 min
later by adding cold glycine buffer. Basal, assays in the absence of
mitochondrial respiration inhibitors; Rot, assays in the presence of
1 lM rotenone; AA, assays in the presence of 10 lM antimycin A. The
results of H2O2 detection are given as a percentage (%) of the control
value (mitochondria not treated with sildenafil citrate) of the respective
experimental condition tested. *P \ 0.05; **P \ 0.01; ***P \ 0.001
statistically significant when compared to the control (100%). Control
values, expressed in nmol H2O2 mg
-1 protein 15 min-1: Basal = 2.61
± 1.0; Rot = 8.07 ± 1.89; AA = 34.13 ± 10.71. *P \ 0.05;
**P \ 0.01; ***P \ 0.001 statistically significant when compared to
the control value of the respective experimental condition tested. The
results correspond to the mean ± SE of three experiments obtained
from different mitochondrial preparations
Fig. 7 Comparative effects of sildenafil citrate (Sil) and superoxide
dismutase (SOD) on the reduction rate of nitroblue tetrazolium (NBT)
by the superoxide radical (O2
•-) generated in a xanthine/xantine
oxidase system. The assays were performed as described in the
‘‘Materials and methods’’ section. The rate of reduction of NBT,
inhibited by SOD or Sil, is plotted as the reciprocal absorbancy change
per minute versus units of SOD activity, or concentration of Sil,
respectively. Inset: relationship between the SOD-like activity of
sildenafil citrate, and sildenafil citrate concentration. The SOD-like
activity of sildenafil citrate, for each concentration of sildenafil citrate,
was calculated using the equation for the linear fit of the curve of SOD,
y = 44.171 + 38.22x, with a correlation coefficient, R = 0.99512,
meaning that 99% of the dependent variable variation (1/D absorbancy
min-1) is explained by the independent variable [SOD (U)]
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The concentrations of sildenafil citrate with antioxidant
action in isolated heart mitochondria (Fig. 6) cannot be
related to the protective concentrations used against
ischemia/reperfusion injury in cardiomyocytes [18] and in
isolated working heart model [35], because the conditions
used and the parameters evaluated are different.
Like sildenafil citrate, other clinically approved PDE5
inhibitors (vardenafil and tadalafil), induce cardioprotective
effects against ischemia/reperfusion injury [9, 11, 36–38].
It is believed that both sildenafil and vardenafil limit
myocardial infarction through opening of the mitochon-
drial KATP channels [11, 36, 38], but the possibility of the
same mechanism of action to be involved in the tadalafil
effect is less clear [37]. In fact, the molecular structures of
vardenafil and sildenafil are similar as compared with that
of tadalafil [3, 7]. Nevertheless, it is difficult to foresee if
these two compounds have similar or different effects to
those described, in this study, for sildenafil citrate, because
their influences on mitochondrial function and oxidative
stress have not been studied.
In conclusion, at concentrations that did not affect heart
mitochondrial bioenergetics and Ca2+-induced permeabil-
ity transition, sildenafil citrate protects heart mitochondria
against H2O2 generation by acting as a SOD-mimetic.
Heart ischemia induces increased generation of ROS, and
subsequent reperfusion could result in toxic ROS over-
production that possibly contributes to irreversible damage
of mitochondrial function and consequent impaired
recovery of physiological function and cell death [13–15,
39, 40]. Hence, the antioxidant capacity of sildenafil cit-
rate might be relevant to protect heart mitochondria
against oxidative stress induced by ischemia/reperfusion
injury and it may, putatively, contribute to its cardiopro-
tective action. Moreover, mitoKATP channels act as ROS
sensors capable of regulating ROS release in response to
changes in mitochondrial redox-state [41]. In isolated
heart, brain and liver mitochondria it was shown that
conditions that increase mitoKATP activity decrease ROS
release [42]. According to these statements, the possibility
of sildenafil citrate to contribute to mitoKATP opening
through changes in the mitochondrial redox status cannot
be excluded.
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